(Total Views: 417)
Posted On: 04/19/2021 5:09:29 PM
Post# of 145248
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: reallypeople? #87169
Reduction in CTCs could not be a primary endpoint. The FDA wants to see results that are a beneficial clinical result to the patient.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)